Neuronal differentiation regulator CEND1 coordinately suppresses tumor growth and energetics via AMPK signaling in brain glioma
Open Access
- 14 November 2025
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 15 (1) , 156
Abstract
The aggressive proliferation and metabolic adaptability of glioma contribute to poor clinical prognosis, necessitating novel targets concurrently reprogram glioma cells toward a neuron-like, less proliferative, and metabolically suppressed state. Here, we identified neuronal differentiation factor CEND1 as a candidate and explored its impact on glioma growth and metabolism. We demonstrated that CEND1 was significantly reduced in high-grade gliomas and inversely correlated with patient survival. Elevated CEND1 in glioma cells induced a neuron-like morphology, accompanied with attenuated proliferation and migration. CEND1 overexpression suppressed tumor growth and prolonged the survival of animal models of intracranial orthotopic tumor formation. Metabolomics and biochemical assays revealed that CEND1 inhibited PDH activity and mitochondrial oxidative phosphorylation, ultimately reducing ATP levels. Mechanistically, CEND1 activated AMPK to induce cell proliferation arrest and enhance metformin sensitivity. Altogether, our findings reveal that CEND1 coordinates neuronal differentiation with mitochondrial energetic metabolic suppression to exert anti-proliferative function in glioma, supporting its role as a potential target for glioma therapy.Keywords
This publication has 43 references indexed in Scilit:
- Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for GliomasMolecular Biotechnology, 2024
- Doxorubicin downregulates autophagy to promote apoptosis-induced dilated cardiomyopathy via regulating the AMPK/mTOR pathwayBiomedicine & Pharmacotherapy, 2023
- Rheb mediates neuronal-activity-induced mitochondrial energetics through mTORC1-independent PDH activationDevelopmental Cell, 2021
- Combination immunotherapy strategies for glioblastomaJournal of Neuro-Oncology, 2021
- Circadian Rheb oscillation alters the dynamics of hepatic mTORC1 activity and mitochondrial morphologyFEBS Letters, 2020
- Transient Receptor Potential V Channels Are Essential for Glucose Sensing by Aldolase and AMPKCell Metabolism, 2019
- Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma AggressivenessCell Reports, 2019
- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With GlioblastomaJAMA, 2017
- Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain MetastasesCell, 2014
- Cell death and neuronal differentiation of glioblastoma stem‐like cells induced by neurogenic transcription factorsGlia, 2012